Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana Harder

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Plos One|April 16, 2011
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomasLeandro Cerchietti, Christine Damm-Welk, Inga Vater, et al.
British Journal of Haematology|February 13, 2003
Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypesDouglas E Horsman, Ichiro Okamoto, Olga Ludkovski, et al.
Genes, Chromosomes & Cancer|March 16, 2012
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotypeItziar Salaverria, Takashi Akasaka, Stefan Gesk, et al.
Leukemia & Lymphoma|September 17, 2004
Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH statusSoo-Zin Kim, Kai Uwe Chow, Natasa Kukoc-Zivojnov, et al.
Genes, Chromosomes & Cancer|June 12, 2003
Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasmsDoris Steinemann, Stefan Gesk, Yanming Zhang, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtapositionStefanie Bug, Jan Dürig, Florian Oyen, et al.
International Journal of Cancer|December 13, 2002
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2Stefan Joos, Martin Granzow, Heidi Holtgreve-Grez, et al.
International Journal of Cancer|March 29, 2002
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain lociJosé I Martín-Subero, Lana Harder, Stefan Gesk, et al.
British Journal of Haematology|February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomasChalid Assaf, Michael Hummel, Edgar Dippel, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Plos One|April 16, 2011
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomasLeandro Cerchietti, Christine Damm-Welk, Inga Vater, et al.
British Journal of Haematology|February 13, 2003
Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypesDouglas E Horsman, Ichiro Okamoto, Olga Ludkovski, et al.
Genes, Chromosomes & Cancer|March 16, 2012
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotypeItziar Salaverria, Takashi Akasaka, Stefan Gesk, et al.
Leukemia & Lymphoma|September 17, 2004
Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH statusSoo-Zin Kim, Kai Uwe Chow, Natasa Kukoc-Zivojnov, et al.
Genes, Chromosomes & Cancer|June 12, 2003
Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasmsDoris Steinemann, Stefan Gesk, Yanming Zhang, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtapositionStefanie Bug, Jan Dürig, Florian Oyen, et al.
International Journal of Cancer|December 13, 2002
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2Stefan Joos, Martin Granzow, Heidi Holtgreve-Grez, et al.
International Journal of Cancer|March 29, 2002
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain lociJosé I Martín-Subero, Lana Harder, Stefan Gesk, et al.
British Journal of Haematology|February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomasChalid Assaf, Michael Hummel, Edgar Dippel, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Pageof 6